Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have received a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $23.60.

Several research analysts have commented on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Barclays lowered their target price on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. TD Cowen reaffirmed a “buy” rating on shares of Alignment Healthcare in a research note on Monday, August 3rd. JPMorgan Chase & Co. dropped their price target on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, August 4th. Finally, Raymond James Financial downgraded shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and cut their price target for the company from $22.00 to $19.00 in a report on Monday, August 3rd.

Insider Activity

In related news, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the completion of the transaction, the president owned 947,313 shares in the company, valued at $18,519,969.15. The trade was a 3.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Joseph S. Konowiecki sold 25,000 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the transaction, the executive vice president directly owned 1,103,816 shares in the company, valued at $26,491,584. This trade represents a 2.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,009,951 shares of company stock valued at $18,597,287. 5.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Alignment Healthcare

A number of large investors have recently made changes to their positions in ALHC. Allworth Financial LP increased its stake in Alignment Healthcare by 8.9% in the 4th quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock worth $137,000 after buying an additional 566 shares during the period. State of Alaska Department of Revenue boosted its position in Alignment Healthcare by 6.0% in the 4th quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock valued at $223,000 after buying an additional 636 shares during the period. Integrated Wealth Concepts LLC grew its stake in Alignment Healthcare by 6.3% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after acquiring an additional 665 shares in the last quarter. Parallel Advisors LLC grew its stake in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares in the last quarter. Finally, Tidal Investments LLC increased its position in shares of Alignment Healthcare by 4.9% during the second quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock worth $253,000 after acquiring an additional 852 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Trading Up 0.4%

Shares of NASDAQ ALHC opened at $13.62 on Friday. Alignment Healthcare has a 1-year low of $12.70 and a 1-year high of $25.12. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The business’s 50 day moving average is $18.09 and its two-hundred day moving average is $18.53. The stock has a market capitalization of $2.83 billion, a P/E ratio of 71.69 and a beta of 1.10.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company’s revenue for the quarter was up 31.6% on a year-over-year basis. During the same period last year, the company earned $0.07 EPS. As a group, research analysts expect that Alignment Healthcare will post 0.17 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.